NL-OMON28293
Recruiting
Not Applicable
Intraoperative near-infrared fluorescence imaging of endometriosis with OTL38: a pilot study
ConditionsEndometriosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endometriosis
- Sponsor
- MC
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Female (premenopausal) patients 18 years of age and older
- •2\.Patients scheduled for elective surgery (laparoscopic or laparotomy) for the diagnosis or treatment of endometriosis
- •3\.WHO performance score of 0\-2
- •4\.A negative serum pregnancy test at screening followed by a negative serum urine pregnancy test on the day of surgery or day of admission for female patients of childbearing potential
- •5\.Female patients of childbearing potential agree to use an acceptable form of contraception from the time of signing informed consent until 930 days after study completion
- •6\.Ability to understand the requirements of the study, provide written informed consent and authorization of use and disclosure of protected health information, and agree to abide by the study restrictions
Exclusion Criteria
- •1\.Previous exposure to OTL38
- •2\.Any medical condition that in the opinion of the investigators could potentially jeopardize the safety of the patient
- •3\.History of anaphylactic reactions
- •4\.History of allergy to any of the components of OTL38, including folic acid
- •5\.Pregnancy (or positive pregnancy test) or breast\-feeding
- •6\.Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule
- •7\.Impaired renal function defined as eGFR\< 50 mL/min/1\.73m2
- •8\.Impaired liver function defined as values \> 3x the upper limit of normal (ULN) for alanine aminotransferase (ALT) or aspartate aminotransferase (AST), alkaline phosphatase (ALP), or total bilirubin
- •9\.Received an investigational agent in another investigational drug or vaccine trial within 30 days prior to surgery
- •10\.Known sensitivity to fluorescent light
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Intraoperative near-infrared fluorescence imaging of endometriosis with OTL38: a pilot studyEUCTR2018-003693-27-NLeiden University Medical Center15
Recruiting
Not Applicable
Intraoperative near-infrared fluorescence imaging using indocyanine green during staging laparoscopy for detecting small metastasis in pancreatic cancer: A prospective studypancreatic cancerJPRN-UMIN000025900Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine40
Recruiting
Phase 2
IR fluorescence imaging during staging laparoscopy for detecting metastases in pancreatic cancerPancreatic cancerPancreatic cancer, Staging laparoscopyC535836JPRN-jRCT1051180076Fukumoto Takumi40
Recruiting
Phase 2
Intraoperative near-infrared fluorescence imaging of colorectal carcinoma with cRGD-ZW800-1 and dedicated imaging systems: A Phase II studyNL-OMON50658eids Universitair Medisch Centrum18
Active, not recruiting
Phase 1
ear-infrared fluorescence imaging with cRGD-ZW800-1 in patients with colorectal carcinomaEUCTR2017-002772-60-NLeiden University Medical Center12